This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Tavazoie, M. F. et al. LXR/ApoE activation restricts innate immune suppression in cancer. Cell https://doi.org/10.1016/j.cell.2017.12.026 (2018)
Rights and permissions
About this article
Cite this article
Killock, D. Targeting MDSCs with LXR agonists. Nat Rev Clin Oncol 15, 200–201 (2018). https://doi.org/10.1038/nrclinonc.2018.17
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrclinonc.2018.17